Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0013
+0.0001 (8.33%)
At close: Dec 19, 2025
Halberd Market Cap
Halberd has a market cap or net worth of $919.49 thousand as of December 19, 2025. Its market cap has decreased by -56.18% in one year.
Market Cap
919.49K
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 919.49K, a decrease of -64.71%. That is a compound annual growth rate of -6.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 919.49K | -63.85% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | 8.34M | 1,228.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |